Solid-phase preparation of a pilot library derived from the 2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine Scaffold

Journal of Combinatorial Chemistry

Volumn 9, Issue 3, 2007, Pages 487-500

  Boeglin, Damien ^a,b   Bonnet, Dominique ^a   Hibert, Marcel ^a  

^a Laboratoire de Pharmacochimie   (France)

^b Alsachim   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAZEPINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; METHODOLOGY; STEREOISOMERISM; SYNTHESIS;

BENZAZEPINES; COMBINATORIAL CHEMISTRY TECHNIQUES; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 34249929781     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc060164x     Document Type: Article

References (77)

1. Bräse, S.; Gil, C.; Knepper, K. Bioorg. Med. Chem. 2002, 10, 2415-2437 and references cited therein.
2. Kamal, A.; Reddy, K. L.; Devaiah, V.; Shankaraiah, N.; Reddy, D. R. Mini-Rev. Med. Chem. 2006, 6, 53-69.
3. Im, I.; Webb, T. R.; Gong, Y. D.; Kim, J. I.; Kim, Y. C. J. Comb. Chem. 2004, 6, 207-213.
4. Wu, Z.; Ercole, F.; FitzGerald, M.; Perera, S.; Riley, P.; Campbell, R.; Pham, Y.; Rea, P.; Sandanayake, S.; Mathieu, M. N.; Bray, A. M.; Ede, N. J. J. Comb. Chem. 2003, 5, 166-171.
5. Ettmayer, P.; Chloupek, S.; Weigand, K. J. Comb. Chem. 2003, 5, 253-259.
6. Herpin, T. F.; Van Kirk, K. G.; Salvino, J. M.; Yu, S. T.; Labaudiniere, R. F. J. Comb. Chem. 2000, 2, 513-521.
7. Hone, N. D.; Wilson, W.; Reader, J. C. Tetrahedron Lett. 2003, 44, 8493-8495.
8. Ali, F. E.; Yuan, C. C. K; Ross, S. T.; Hall, R. L. B. Mol. Diversity 2000, 5, 1-5.
9. Van den Eynde, I.; Van Rompaey, K.; Lazzaro, F.; Tourwé, D. J. Comb. Chem. 2004, 6, 468-473.
10. Nefzi, A.; Ong, N. A.; Houghten, R. A. Tetrahedron Lett. 2001, 42, 5141-5143.
11. Bevacqua, F.; Basso, A.; Gitto, R.; Bradley, M.; Chimirri, A. Tetrahedron Lett. 2001, 42, 7683-7685.
12. Leukotrine synthesis inhibitor: Shih, N.-Y.; Mangiaracina, P.; Green, M. J.; Ganguly, A. K. Aryl substituted naphatalene, benzaxepine, benzazepine, benzacycloheptene derivatives. WO 08808836, 1988.
13. 5-Lipoxygenase inhibitor: Takafumi, I.; Yoko; Hoshino, Y. Tetrahydrobenzazepine derivatives which inhibit lipoxygenase. WO 9300335, 1993.
14. Acetylcholinesterase inhibitor: (a) Goto, G.; Ishihara, Y.; Miyamoto, M. Condensed heterocyclic compounds, their production and use. EP 487071, 1992.
15. (b) Ishihara, Y.; Hirai, K.; Miyamoto, M.; Goto, G. J. Med. Chem. 1994, 37, 2292-2299.
16. CETP inhibitors: Guoqing, C.; Escribano, A. M.; Fernandez, M. C.; Fields, T.; Gernert, D. L.; Cioffi, C. L.; Herr, R. J.; Mantlo, N. B.; Martin de la Nava, E. M.; Mateo Herranz, A. I.; Mayhugh, D. R.; Wang, X. Compounds and methods for treating dyslipidemia. WO 2005037796, 2005.
17. Factor Xa inhibitors: Jacobson, I. C.; Quan, M. L. Nitrogen containing heterobicycles as factor Xa inhibitors. WO 0105784, 2001.
18. 5HT3 antagonist: Pelletier, J. C.; Youssefyeh, R. D.; Campbell, H. F. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents. WO 9006113, 1990.
19. RXR agonist: Hibi, S.; Kikuchi, K.; Yoshimura, H.; Nagai, M.; Tagami, K.; Abe, S.; Hishinula, I.; Nagakawa, J.; Miyamoto, N.; Hida, T.; Ogasawara, A.; Higashi, S.; Tai, K.; Yamanaka, T.; Asasa, M. Mono- or polyenic carboxylic acid derivatives. US 6,420,363, 2002.
20. MBR antagonist: Takuya, S.; Seishi, K.; Masashi, K.; Junichiro, M.; Ohmoto, K. N-carbanoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient. WO 03068753, 2003.
21. Inhibitor N-type calcium channels: Takuya, E.; Kazuya, H. Benzazepine derivative. JP 2002363163, 2002.
22. 2 antagonist: (a) Ogawa, H.; Miyamoto, H.; Kondo, K.; Yamashita, H.; Nakaya, K. Komatsu, H.; Tanaka, M. Benzoheterocyclic compounds. WO 9105549, 1991.
23. (b) Yamamura, Y.; Ogawa, H.; Yamashita, H.; Chihara, T.; Miyamoto, H.; Nakamra, S.; Onogawa, T.; Yamashita, T.; Hosokawa, Y.; Mori, T. Br. J. Pharmacol. 1992, 105, 787-791.
24. (c) Martinez-Castelao, A. Curr. Opin. Investig. Drugs 2001, 2, 525-530.
25. (d) Albright, J. D.; Reich, M. V.; Delos Santos, E. G. D.; Dusza, J. P.; Sum, F. W.; Venkatesan, A. M.; Coupet, J.; Chan, P. S.; Ru, X.; Mazandarani, H.; Bailey, T. J. Med. Chem. 1998, 41, 2442-2444.
26. 2 agonist: (a) Caggiano, T. J. Drugs Fut. 2002, 27, 248.
27. (b) Kondo, K.; Kan, K.; Tanada, Y.; Bando, M.; Shinohara, T.; Kurimura, M.; Ogawa, H.; Nakamura, S.; Hirano, T.; Yamamura, Y.; Kido, M.; Mon, T.; Tominaga, M. J. Med. Chem. 2002, 45, 3805-3808.
28. (c) Failli, A. A.; Shumsky, J. S.; Steffan, R. J.; Caggiano, T. J.; Williams, D. K.; Trybulski, E. J.; Ning, X.; Lock, Y.; Tanikella, T.; Hartmann, D.; Chan, P. S.; Park, C. H. Bioorg. Med. Chem. Lett. 2006, 16, 954-959.
29. Oxytocin antagonist: (a) Wyatt, P. G.; Allen, M. J.; Chilcott, J.; Hickin, G.; Millera, N. D.; Woollard, P.M. Bioorg. Med. Chem. Lett. 2001, 11, 1301-1305.
30. (b) Williams, P. D.; Bock, M. G.; Evans, B. E.; Freidinger, R. M.; Gallicchio, S. N.; Guidotti, M. T.; Jacobson, M. A.; Kuo, M. S.; Levy, M. R.; Lis, E. V.; Michelson, S. R.; Pawluczyk, J. M.; Perlow, D. S.; Pettibone, D. J.; Quigley, A. G.; Reiss, D. R.; Salvatore, C.; Stauffer, K. J.; Woyden, C. J. Bioorg. Med. Chem. Lett. 1999, 9, 1311-1316.
31. Oxytocin agonist: Pitt, G. R. W.; Batt, A. R.; Haigh, R. M.; Penson, A. M.; Robson, P. A.; Rooker, D. P.; Tartar, A. L.; Trim, J. E.; Yeaa, C. M.; Roea, M. B. Bioorg. Med. Chem. Lett. 2004, 14, 4585-4589.
32. GHS agonist: Li, J. J. Benzoazepines and analogs thereof useful as growth hormone secretagogues. WO 0024398, 2000.
33. LHRH antagonist: Kazumasa, H.; Tsuneo, O.; Masami, K.; Naoyuki, K. Fused pyrimidine derivative and use thereof. WO 2005019188, 2005.
34. CCR5 antagonist: Seto, M.; Miyamoto, N;. Aikawa, K.; Aramaki, Y.; Kanzaki, N.; lizawa, Y.; Baba, M.; Shiraishi, M. Biorg. Med. Chem. 2005, 13, 363-383.
35. Tahtaoui, C.; Balestre, M.-N.; Klotz, P.; Rognan, D.; Barberis, C.; Mouillac, B.; Hibert, M. J. Biol. Chem. 2003, 278, 40010-40019.
36. Me Call, I.; Proctor, G. R.; Purdie, L. J. Chem. Soc. (C) 1970, 1126-1128.
37. (a) Proctor, G. R.; Thomson, R. H. J. Chem. Soc. 1957, 2312-2314.
38. (b) Proctor, G. R. J. Chem. Soc. 1961, 3989-3994.
39. (c) Bell, W. H.; Hannah, E. D.; Proctor, G. R. J. Chem. Soc. 1964, 4926-4930.
40. Microwave irradiation (120°C, 15 min) could be alternatively used to remove the Ts group with a similar result.
41. Three alternative protecting groups orthogonal to acid-labile linkers were evaluated but found either not compatible with our synthetic scheme (Fmoc) or not convenient/amenable for preparation of a large library (Alloc, oNS).
42. Zhi, L.; Tegley, C. M.; Marschke, K. B.; Jones, T. K. Bioorg. Med. Chem. Lett. 1999, 9, 1009-1012.
43. Liu, Y.; McWhorter, W. W., Jr. J. Am. Chem. Soc. 2003, 125, 4240-4252.
44. Wang, Z.; Yang, D.; Mohanakrishnan, A. K;. Fanwick, P. E.; Nampoothiri, P.; Harnel, E.; Cushman, M. J. Med. Chem. 2000, 43, 2419-2429.
45. (a) Morphy, J. R.; Rankovic, Z.; Rees, D. C. Tetrahedron Lett. 1996, 37, 3209-3212.
46. (b) Brown, A. R.; Rees, D. C.; Rankovic, Z.; Morphy, J. R. J. Am. Chem. Soc. 1997, 119, 3288-3295.
47. (a) Bräse, S.; Enders, D.; Köbberling, J.; Avemaria, F. Angew. Chem., Int. Ed. 1998, 37, 3413-3415.
48. (b) Bräse, S.; Dahmen, S.; Pfefferkorn, M. J. Comb. Chem. 2000, 2, 710-715.
49. Olsena, C. A.; Wittb, M.; Hansenc, S. H.; Jaroszewskia, J. W.; Franzyka, H. Tetrahedron 2005, 61, 6046-6055.
50. (a) Gouilleux, L.; Fehrentz, J. A.; Winternitz, F.; Martinez, J. Tetrahedron Lett. 1996, 37, 7031-7034.
51. (b) Dressman, B. A.; Spangle, L. A.; Kaldor, S. W. Tetrahedron Lett. 1996, 37, 937-940.
52. Jensen, K. J.; Alsina, J.; Songster, M. F.; Vagner, J.; Albericio, F.; Barany, G. J. Am. Chem. Soc. 1998, 120, 5441-5452.
53. Farrant, E.; Rahman, S. S. Tetrahedron Lett. 2000, 41, 5383-5386.
54. Makara, G. M.; Ma, Y. Tetrahedron Lett. 2001, 42, 4123-4125.
55. Yan, B.; Nguyen, N.; Liu, L.; Holland, G.; Raju, B. J. Comb. Chem. 2000, 2, 66-74.
56. Forns, P.; Sevilla, S.; Erra, M.; Ortega, A.; Fernandez, J. C.; De la Giguera, N.; Fernandez-Forner, D.; Albericio, F. Tetrahedron Lett. 2003, 44, 6907-6910.
57. Boguszewski, P. A.; Rahman, S. S.; Ganesan, A. J. Comb. Chem. 2004, 6, 32-34.
58. Shannon, S. K.; Barany, G. J. Comb. Chem. 2004, 6, 165-170.
59. (a) Vojkovsky, T. Pept. Res. 1995, 8, 236-237.
60. (b) Christensen, T. Acta Chem. Scand. B 1979, 33, 763-766.
61. Zhang, A. J.; Russell, D. H.; Zhu, J.; Burgess, K. Tetrahedron Lett. 1998, 39, 7439-7442.
62. Lejeune, V.; Martinez, J.; Cavalier, F. Tetrahedron Lett. 2003, 44, 4757-4759.
63. 2 in DCM at reflux for 2 h.
64. Falb, E.; Yechezkel, T.; Salitra, Y.; Gilon, C. J. Pept. Res. 1999, 53, 507.
65. Bonnet, D.; Ganesan, A. J. Comb. Chem. 2002, 4, 546-548.
66. For a review on Pd-catalyzed reaction performed on a solid-supported substrate see: Bräse, S.; Kirchhoff, J. K.; Köbberling, J. Tetrahedron 2003, 59, 885-939.
67. Fernàndez, J.-C.; Solé-Feu, L.; Fernández-Forner, D.; De la Figuera, N.; Forns, P.; Albericio, A. Tetrahedron Lett. 2005, 46, 581-585.
68. Lee, Y.; Kelly, J. K. Tetrahedron Lett. 2006, 47, 4897-4901.
69. Ward, Y. D.; Farina, V. Tetrahedron Lett. 1996, 37, 6993-6996.
70. Willoughby, C. A.; Chapman, K. T. Tetrahedron Lett. 1996, 37, 7181-7184.
71. Yamamoto, T.; Nishiyama, M.; Koie, Y. Tetrahedron Lett. 1998, 39, 2367-2370.
72. Wolfe, J. P.; Buchwald, S. L. J. Org. Chem. 2000, 65, 1144-1157.
73. (a) O'Brien, C. J.; Kantchev, E. A.; Valente, C.; Hadei, N.; Chass, G. A.; Lough, A.; Hopkinson, A. C.; Organ, M. G. Chem-Eur. J. 2006, 12, 4743-4748.
74. (b) Organ, M. G.; Avola, S.; Dubovyk, I.; Hadei, N.; Kantchev, E. A.; O'Brien, C. J.; Valente, C. Chem-Eur. J. 2006, 12, 4749-4755.
75. (c) Dubovyk, I.; Avola, S.; Kantchev, E. A. B.; O'Brien, C.; Organ, M. G.; Valente, C. Use of PEPPSI Catalyst in Buchwald-Hartwig Amination Reactions. Presented at the 34th SOUSCC, Toronto, Canada, March 18, 2006.
76. (d) Kantchev, E. A. B.; O'Brien, C. J.; Organ, M. G. Aldrichim. Acta 2006, 39 (4), 97-111.
77. Matsubara, J.; Kitano, K.; Otsubo, K.; Kawano, Y.; Ohtani, T.; Bando, M.; Kido, M.; Uchida, M.; Tabusa, F. Tetrahedron 2000, 56, 4667-4682.